405
Views
8
CrossRef citations to date
0
Altmetric
Articles

A nanocarrier for the mitochondrial delivery of nucleic acids to cardiomyocytes

, &
Pages 141-155 | Received 18 Aug 2019, Accepted 26 Sep 2019, Published online: 09 Oct 2019

References

  • Dominic, E. A.; Ramezani, A.; Anker, S. D.; Verma, M.; Mehta, N.; Rao, M. Mitochondrial Cytopathies and Cardiovascular Disease. Heart 2014, 100, 611–618. DOI: 10.1136/heartjnl-2013-304657.
  • Lee, S. R.; Han, J. Mitochondrial Mutations in Cardiac Disorders. Adv. Exp. Med. Biol. 2017, 982, 81–111. DOI: 10.1007/978-3-319-55330-6_5.
  • Yamada, Y.; Harashima, H. Mitochondrial Drug Delivery Systems for Macromolecule and Their Therapeutic Application to Mitochondrial Diseases. Adv. Drug Deliv. Rev. 2008, 60, 1439–1462. DOI: 10.1016/j.addr.2008.04.016.
  • Biswas, S.; Torchilin, V. P. Nanopreparations for Organelle-Specific Delivery in Cancer. Adv. Drug Deliv. Rev. 2014, 66, 26–41. DOI: 10.1016/j.addr.2013.11.004.
  • Milane, L.; Trivedi, M.; Singh, A.; Talekar, M.; Amiji, M. Mitochondrial Biology, Targets, and Drug Delivery. J. Control. Release 2015, 207, 40–58. DOI: 10.1016/j.jconrel.2015.03.036.
  • Wen, R.; Banik, B.; Pathak, R. K.; Kumar, A.; Kolishetti, N.; Dhar, S. Nanotechnology Inspired Tools for Mitochondrial Dysfunction Related Diseases. Adv. Drug Deliv. Rev. 2016, 99, 52–69. DOI: 10.1016/j.addr.2015.12.024.
  • Sato, Y.; Sakurai, Y.; Kajimoto, K.; Nakamura, T.; Yamada, Y.; Akita, H.; Harashima, H. Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/from Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics. Macromol. Biosci. 2017, 17, 1600179. DOI: 10.1002/mabi.201600179.
  • Nakamura, T.; Yamada, Y.; Sato, Y.; Khalil, I. A.; Harashima, H. Innovative Nanotechnologies for Enhancing Nucleic Acids/Gene Therapy: Controlling Intracellular Trafficking to Targeted Biodistribution. Biomaterials 2019, 218, 119329. DOI: 10.1016/j.biomaterials.2019.119329.
  • Yamada, Y.; Akita, H.; Kamiya, H.; Kogure, K.; Yamamoto, T.; Shinohara, Y.; Yamashita, K.; Kobayashi, H.; Kikuchi, H.; Harashima, H. MITO-Porter: A Liposome-Based Carrier System for Delivery of Macromolecules into Mitochondria via Membrane Fusion. Biochim. et Biophys. Acta 2008, 1778, 423–432. DOI: 10.1016/j.bbamem.2007.11.002.
  • Yamada, Y.; Nakamura, K.; Abe, J.; Hyodo, M.; Haga, S.; Ozaki, M.; Harashima, H. Mitochondrial Delivery of Coenzyme Q10 via Systemic Administration Using a MITO-Porter Prevents Ischemia/Reperfusion Injury in the Mouse Liver. J Control. Release 2015, 213, 86–95. DOI: 10.1016/j.jconrel.2015.06.037.
  • Yamada, Y.; Furukawa, R.; Yasuzaki, Y.; Harashima, H. Dual Function MITO-Porter, a Nano Carrier Integrating Both Efficient Cytoplasmic Delivery and Mitochondrial Macromolecule Delivery. Mol. Ther. 2011, 19, 1449–1456. DOI: 10.1038/mt.2011.99.
  • Furukawa, R.; Yamada, Y.; Kawamura, E.; Harashima, H. Mitochondrial Delivery of Antisense RNA by MITO-Porter Results in Mitochondrial RNA Knockdown, and Has a Functional Impact on Mitochondria. Biomaterials 2015, 57, 107–115. DOI: 10.1016/j.biomaterials.2015.04.022.
  • Takano, Y.; Munechika, R.; Biju, V.; Harashima, H.; Imahori, H.; Yamada, Y. Optical Control of Mitochondrial Reductive Reactions in Living Cells Using an Electron Donor-Acceptor Linked Molecule. Nanoscale 2017, 9, 18690–18698. DOI: 10.1039/C7NR06310E.
  • Abe, J.; Yamada, Y.; Takeda, A.; Harashima, H. Cardiac Progenitor Cells Activated by Mitochondrial Delivery of Resveratrol Enhance the Survival of a Doxorubicin-Induced Cardiomyopathy Mouse Model via the Mitochondrial Activation of a Damaged Myocardium. J. Control. Release 2018, 269, 177–188. DOI: 10.1016/j.jconrel.2017.11.024.
  • Ishikawa, T.; Somiya, K.; Munechika, R.; Harashima, H.; Yamada, Y. Mitochondrial Transgene Expression via an Artificial Mitochondrial DNA Vector in Cells from a Patient with a Mitochondrial Disease. J. Control. Release 2018, 274, 109–117. DOI: 10.1016/j.jconrel.2018.02.005.
  • Yamada, Y.; Daikuhara, S.; Tamura, A.; Nishida, K.; Yui, N.; Harashima, H. Enhanced Autophagy Induction via the Mitochondrial Delivery of Methylated Beta-Cyclodextrin-Threaded Polyrotaxanes Using a MITO-Porter. Chem. Commun. 2019, 55, 7203–7206. DOI: 10.1039/C9CC03272J.
  • Yamada, Y.; Tabata, M.; Yasuzaki, Y.; Nomura, M.; Shibata, A.; Ibayashi, Y.; Taniguchi, Y.; Sasaki, S.; Harashima, H. A Nanocarrier System for the Delivery of Nucleic Acids Targeted to a Pancreatic Beta Cell Line. Biomaterials 2014, 35, 6430–6438. DOI: 10.1016/j.biomaterials.2014.04.017.
  • Katayama, T.; Kinugawa, S.; Takada, S.; Furihata, T.; Fukushima, A.; Yokota, T.; Anzai, T.; Hibino, M.; Harashima, H.; Yamada, Y. A Mitochondrial Delivery System Using Liposome-Based Nanocarriers That Target Myoblast Cells. Mitochondrion 2019, 49, 66–72. DOI: 10.1016/j.mito.2019.07.005.
  • Kusumoto, K.; Akita, H.; Ishitsuka, T.; Matsumoto, Y.; Nomoto, T.; Furukawa, R.; El-Sayed, A.; Hatakeyama, H.; Kajimoto, K.; Yamada, Y.; et al. Lipid Envelope-Type Nanoparticle Incorporating a Multifunctional Peptide for Systemic siRNA Delivery to the Pulmonary Endothelium. ACS Nano 2013, 7, 7534–7541. DOI: 10.1021/nn401317t.
  • Yamada, Y.; Ishikawa, T.; Harashima, H. Validation of the Use of an Artificial Mitochondrial Reporter DNA Vector Containing a Cytomegalovirus Promoter for Mitochondrial Transgene Expression. Biomaterials 2017, 136, 56–66. DOI: 10.1016/j.biomaterials.2017.05.016.
  • Futaki, S.; Ohashi, W.; Suzuki, T.; Niwa, M.; Tanaka, S.; Ueda, K.; Harashima, H.; Sugiura, Y. Stearylated Arginine-Rich Peptides: A New Class of Transfection Systems. Bioconjugate Chem. 2001, 12, 1005–1011. DOI: 10.1021/bc015508l.
  • Yamada, Y.; Furukawa, R.; Harashima, H. A Dual-Ligand Liposomal System Composed of a Cell-Penetrating Peptide and a Mitochondrial RNA Aptamer Synergistically Facilitates Cellular Uptake and Mitochondrial Targeting. J. Pharm. Sci. 2016, 105, 1705–1713. DOI: 10.1016/j.xphs.2016.03.002.
  • Wang, G.; Chen, H. W.; Oktay, Y.; Zhang, J.; Allen, E. L.; Smith, G. M.; Fan, K. C.; Hong, J. S.; French, S. W.; McCaffery, J. M.; et al. PNPASE Regulates RNA Import into Mitochondria. Cell 2010, 142, 456–467. DOI: 10.1016/j.cell.2010.06.035.
  • Kawamura, E.; Yamada, Y.; Harashima, H. Mitochondrial Targeting Functional Peptides as Potential Devices for the Mitochondrial Delivery of a DF-MITO-Porter. Mitochondrion 2013, 13, 610–614. DOI: 10.1016/j.mito.2013.08.010.
  • Yasuzaki, Y.; Yamada, Y.; Ishikawa, T.; Harashima, H. Validation of Mitochondrial Gene Delivery in Liver and Skeletal Muscle via Hydrodynamic Injection Using an Artificial Mitochondrial Reporter DNA Vector. Mol. Pharmaceutics 2015, 12, 4311–4320. DOI: 10.1021/acs.molpharmaceut.5b00511.
  • McCully, J. D.; Levitsky, S.; Del Nido, P. J.; Cowan, D. B. Mitochondrial Transplantation for Therapeutic Use. Clin. Transl. Med. 2016, 5, 16. DOI: 10.1186/s40169-016-0095-4.
  • Bertero, E.; Maack, C.; O’Rourke, B. Mitochondrial Transplantation in Humans: “Magical” Cure or Cause for Concern? J. Clin. Invest. 2018, 128, 5191–5194. DOI: 10.1172/JCI124944.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.